Sander Flaum discusses the DISARM act and how we can fight back against antibiotic resistance.
Contrary to popular belief, most Americans like their healthcare and don’t want to change it.
CVS is pushing into primary care. If successful, might this prove that corporations can fulfill the Democratic dream of socialized health?
Sander Flaum is principal of Flaum Navigators.
Even when pharma produces breakthroughs, critics still find something or other to nitpick.
Sander Flaum explains why continued research depends on fair prices for treatments.
Sander Flaum takes a look at why health insurers want to cast pharma as the villain.
Breakthrough drugs will eventually be more affordable, but a misplaced focus on their cost may prevent them from being discovered at all.
As more and more people die from opioid overdoses, it’s time for pharma to own up to its collective responsibility and come up with a solution.
Big pharma should extend its vision beyond the blockbusters to make room for orphan drugs.
Get to know each of these companies by learning about their culture, work/life balance, D&I initiatives and more.
OptimizeRx’s Chris DiCostanzo and Rebecca Love explain the value of reaching patients and HCPs when it matters most.
Talking Medicines’ Jo Halliday discussed how the pharmaceutical sector can better understand the voice of the patient.
Learn about Intouch Group’s journey to foster I+D so that its inclusive culture translates into inclusive healthcare marketing.
Any EHR provider delivering a quality solution should be able to answer these six questions.
Please login or register first to view this content.